Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study

被引:0
|
作者
Chandrasekhar, Jaya [1 ]
Baber, Usman [1 ]
Sartori, Samantha [2 ]
Aquino, Melissa [3 ]
Henry, Timothy D. [4 ]
Kini, Annapoorna [5 ]
Kapadia, Samir [6 ]
Rao, Sunil [7 ]
Weiss, Sandra [8 ]
Muhlestein, Joseph B. [9 ]
Poddar, Kanhaiya L. [6 ]
Baker, Brian A. [10 ]
Keller, Stuart Y. [11 ]
Effron, Mark B. [11 ]
Chao, Jennifer [2 ]
Strauss, Craig E. [12 ]
DeFranco, Anthony [13 ]
Weintraub, William [8 ]
Mehran, Roxana [1 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Mt Sinai Sch Med, New York, NY USA
[3] Icahn Med Mt Sinai, New York, NY USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[5] Mt Sinai, New York, NY USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Christiana Care Hlth Syst, Newark, DE USA
[9] Intermt Med Ctr, Murray, UT USA
[10] Daiichi Sankyo, Parsippany, NJ USA
[11] Eli Lilly & Co, Indianapolis, IN 46285 USA
[12] Abbott NW Hosp, Minneapolis Heart Inst Fdn, Minneapolis, MN 55407 USA
[13] Aurora Cardiovasc Serv, Milwaukee, WI USA
关键词
Acute coronary syndromes; Angioplasty; Antiplatelet therapy;
D O I
10.1016/j.jacc.2015.08.234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TCT-219
引用
收藏
页码:B84 / B85
页数:2
相关论文
共 50 条
  • [31] Use of low-dose prasugrel vs. clopidogrel in elderly patients undergoing complex or non-complex PCI for acute coronary syndromes: insights from the Elderly ACS 2 study
    Montalto, C.
    Crimi, G.
    Fortuni, F.
    Mirizzi, A. Mandurino
    Piatti, L.
    Morici, N.
    Tortorella, G.
    Grosseto, D.
    Sganzerla, P.
    Ferrario, M.
    De Servi, S.
    Savonitto, S.
    EUROPEAN HEART JOURNAL, 2019, 40 : 76 - 76
  • [32] Long-term versus short-term therapy with clopidogrel in patients undergoing coronary stenting (RACS trial): Results from the random Argentine Clopidogrel Cardiology Society (RACS) study
    Szarfer, J
    Serra, W
    Alemparte, MR
    Gabay, J
    Sumay, G
    Sarmiento, R
    Sztejfman, C
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 127L - 127L
  • [33] IMPACT OF PROTON PUMP INHIBITOR USE ON THE COMPARATIVE SAFETY AND EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL: INSIGHTS FROM TRANSLATE-ACS
    Jackson, Larry R.
    Peterson, Eric
    McCoy, Lisa
    Ju, Christine
    Zettler, Marjorie
    Baker, Brian
    Messenger, John
    Faries, Douglas
    Effron, Mark
    Cohen, David
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A225 - A225
  • [34] TICAGRELOR VERSUS TICAGRELOR AND CLOPIDOGREL IN PATIENTS UNDERGOING PRIMARY PCI: A PLATELET REACTIVITY PHARMACODYNAMICS STUDY
    Hibbert, Benjamin M.
    Maze, Ronnen
    Pourdjabbar, Ali
    Simard, Trevor
    Ramirez, Daniel
    Froeschl, Michael
    Dick, Alexander
    Glover, Chris
    Marquis, Jean-Francois
    Labinaz, Marino
    So, Derek
    Le May, Michel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E105 - E105
  • [35] Incidence and effects of stroke, MI and bleeding on mortality among patients with ACS undergoing PCI: a comparative analysis from the PROMETHEUS registry
    Chandiramani, R.
    Chen, H.
    Cao, D.
    Claessen, B.
    Blum, M.
    Goel, R.
    Sartori, S.
    Aquino, M.
    Guedeney, P.
    Effron, M.
    Keller, S.
    Baker, B.
    Pocock, S.
    Baber, U.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1056 - 1056
  • [36] Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
    Koyabu, Yota
    Abe, Shichiro
    Sakuma, Masashi
    Kanaya, Tomoaki
    Obi, Syotaro
    Yonede, Shuichi
    Toyoda, Shigeru
    Nakajima, Toshiaki
    Inoue, Teruo
    INTERNAL MEDICINE, 2019, 58 (16) : 2315 - 2322
  • [37] TICAGRELOR OR PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR CHRONIC CORONARY SYNDROMES: RESULTS FROM A REAL-WORLD REGISTRY
    Koshy, Anoop Ninan
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Smith, Kenneth
    Kumar, Kartik
    Chen, Shiwei
    Krishnamoorthy, Parasuram Melarcode
    Dhulipala, Vishal
    Sweeny, Joseph M.
    Khera, Sahil
    Serrao, Gregory
    Sharma, Raman
    Dangas, George D.
    Kini, Annapoorna Subhash
    Mehran, Roxana
    Sharma, Samin K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1298 - 1298
  • [38] Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes Results From the TRILOGY ACS Trial
    Chin, Chee Tang
    Neely, Benjamin
    Ohman, E. Magnus
    Armstrong, Paul W.
    Corbalan, Ramon
    White, Harvey D.
    Prabhakaran, Dorairaj
    Winters, Kenneth J.
    Fox, Keith A. A.
    Roe, Matthew T.
    STROKE, 2016, 47 (04) : 1135 - 1139
  • [39] Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study
    Jackson, Larry R.
    Ju, Christine
    Zettler, Marjorie
    Messenger, John C.
    Cohen, David J.
    Stone, Gregg W.
    Baker, Brian A.
    Effron, Mark
    Peterson, Eric D.
    Wang, Tracy Y.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (14) : 1880 - 1889
  • [40] Comparative efficacy and safety of ticagrelor vs. prasugrel in patients undergoing PCI for NSTE-ACS. Results of the prospective ALKK-Registry
    Riedmaier, P.
    Hochadel, M.
    Ince, H.
    Darius, H.
    Hoffmeister, T.
    Zahn, R.
    Zeymer, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1263 - 1263